Europe PMC is an archive of life sciences journal literature. Please help EMBL-EBI keep the data flowing to the scientific community! Take part in our Impact Survey (15 minutes).Deepika Polineni is a health care provider registered with National Plan and Provider Enumeration System (NPPES), by the Centers for Medicare & Medicaid Services (CMS). The National Provider Identifier (NPI) is #1043332265. The practice address is 64 E 54th St, Kansas City, MO 64112-2860, US. Published on April 6, 2007.Deepika Polineni, MD/ Ricardo A. Mosquera, MD Sarcoidosis Robert Baughman, MD, PhD/ W. Ennis James, MD/ Connie Hsia, MD/ Haala Rokadia, MD/ Yolanda Mageto, MD, chILD MPH/Lisa Maier, MD Robin Deterding, MD LAM/Tuberous Sclerosis Complex Carlos Girod, MD Lung Transplant John Reynolds, MD Pulmonary Fibrosis Susan K. Mathai, MD/ Traci Adams, MDDeepika Polineni; and others; Cited in Scopus: 1. Preview Hide Preview; Download PDF Export Citation; There is now ample evidence that differences in sex and gender contribute to the incidence, susceptibility, presentation, diagnosis, and clinical course of many lung diseases. Some conditions are more prevalent in women, such as pulmonary ...Florida; Bennie McWilliams, Dell Children’s Medical Group, Austin, Texas; Deepika Polineni, The University of Kansas Medical Center, Kansas City; Brian Morrissey,Deepika Polineni & Theodore Budden. Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, USA. Jianghua He. Pulmonary and Critical Care Medicine, Maine Medical ...6 Department of Pediatrics, Washington University in St. Louis, St. Louis Missouri , USA. PMID: 37700667. DOI: 10.1097/MCP.0000000000001019. Currently, drug development and clinical trials for genetic therapies in CF are rapidly progressing. This review aims to increase the foundational knowledge of CF genetic therapies.Loop is the open research network that increases the discoverability and impact of researchers and their work. Loop enables you to stay up-to-date with the latest discoveries and news, connect with researchers and form …Deepika Polineni worked as an Associate Professor for the University of Kansas Medical Center (KUMC) and in 2022 had a reported pay of $220,000.18 according to public records. This is 201.1 percent higher than the average pay for university and college employees and 217.2 percent higher than the national average for government employees.6 Department of Pediatrics, Washington University in St. Louis, St. Louis Missouri , USA. PMID: 37700667. DOI: 10.1097/MCP.0000000000001019. Currently, drug development and clinical trials for genetic therapies in CF are rapidly progressing. This review aims to increase the foundational knowledge of CF genetic therapies.SPOT ON 2081 Sriwijaya Family Residence, Singosari: See traveler reviews, 5 candid photos, and great deals for SPOT ON 2081 Sriwijaya Family Residence at Tripadvisor.Dr. Matthias A. Salathe is a pulmonologist in Kansas City, Kansas and is affiliated with University of Kansas Hospital. He received his medical degree from University of Basel Faculty of Medicine ...... Polineni, Deepika. / Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a ..."With treatments like this we can actually anticipate that if a young child were started on this therapy they could actually expect to have a normal life expectancy," said Deepika Polineni, a ...Deepika Polineni, MD; Margaret A. Pisani, MD, MPH; Ghada Bourjeily, MD; Marilyn K. Glassberg, MD; and Carolyn D'Ambrosio, MD There is now ample evidence that differences in sex and gender contribute to the incidence, susceptibility, presentation, diagnosis, and clinical course of many lung diseases. Some con-Cystic fibrosis (CF) is one of the commonest lethal inherited conditions among Caucasians. It affects multiple organ systems and exhibits a range of clinical problems of varying severity. Life expectancy has improved in recent years as treatment regimes have become more intensive, but current treatments are expensive, often time consuming and ...University of Kansas - Cited by 2,466 - cystic fibrosis - lung inflammation - extracellular vesicles - primary ciliary dyskinesiaTriple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes. Reply. 2021 Dec 2;385 (23):2208. doi: 10.1056/NEJMc2115966. Deepika Polineni. 34874646.Deepika Polineni, MD, MPH. Associate Professor of Pediatrics, Allergy and Pulmonary Medicine. Director, Cystic Fibrosis Center. Click to see this content.Deepika Polineni and Gregory Gan have launched a trial together exploring a drug that they hope can thwart the "cytokine storm" that causes respiratory failure in some COVID-19 patients. When 2020 began, Gregory Gan, M.D., Ph.D., was all set to dive into new research on treatment resistance and metastasis in head and neck cancer.otypes. However, a significant proportion of the CF population is in need of alternative treatment strategies to address CFTR variants that are ineligible for therapeutic protein correction and/or potentiation. Current drug development efforts of nucleic-acid based therapies (i.e., DNA and RNA based therapies) in CF are informed by historic challenges of CF gene …Deepika Polineni MD. Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. Contribution: Resources (equal), Supervision (supporting), Writing - review & editing (supporting) Search for more papers by this authorSource: Deepika Polineni, MD, MPH Assistant Professor Division of Pulmonary, Critical Care, and Sleep Medicine University of Kansas Medical Center. Quick Facts About Reproductive Health and Lung Disease.17 Kas 2009 ... We hope that our support will be conveyed to the other members of the Board of Alderman. Best regards,. Nirmal Veeramachaneni and Deepika ...Three architecture faculty receive promotions, tenure. Thu, 05/28/20. LAWRENCE — Chancellor Douglas A. Girod has approved promotion and the award of tenure where indicated to 97 individuals on the University of Kansas Medical Center and 62 individuals on the Lawrence and Edwards campuses. Girod and Barbara Bichelmeyer, …Physician-scientists Gregory Gan and Deepika Polineni, who research cancer and cystic fibrosis, have teamed up to test a new drug with the potential to keep COVID-19 patients from needing a ventilator.Dr. Natalie E. West is a Pulmonologist in Baltimore, MD. Find Dr. West's phone number, address, insurance information, hospital affiliations and more.Dr. Deepika Polineni, MD is a Pulmonologist in Saint Louis, MO. Dr. Polineni studied at UNIVERSITY OF MISSOURI / KANSAS CITY CAMPUS. They currently practice at Washington University School Of Medicine In St. Louis and are affiliated with University Of Kansas Hospital.Dr. Charlotte C. Teneback is a Pulmonologist in Burlington, VT. Find Dr. Teneback's phone number, address, insurance information, hospital affiliations and more.Edith T. Zemanick, Deepika Polineni Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic ...Sylvia Mazuera f, Deepika Polineni g, Lori L. Stark h, Cynthia George c, Kristin A. Riekert b a Division of Pulmonary Medicine, Boston Children's Hospital, 333 Longwood Avenue, Boston, MA 02115, USA b Department of Medicine,Division Pulmonary and Critical Care Johns HopkinsUniversity, 5501 Bayview Circle, Baltimore, MD 21224, USADeepika Polineni 1 2 , Annalisa V Piccorelli 3 4 , William B Hannah 1 , Sarah N Dalrymple 1 , Rhonda G Pace 1 , Peter R Durie 5 6 7 , Simon C Ling 6 7 , Michael R Knowles 1 , Jaclyn R Stonebraker 1 AffiliationsThen while on vacation in Colorado, she received a phone call from Deepika Polineni, M.D., MPH, assistant professor of internal medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Kansas Medical Center, and a pulmonologist at the cystic fibrosis clinic for The University of Kansas Health System, where ...and Deepika Polineni, M.D., M.P.H. et al., for the VX18-445-104 Study Group * The members of the VX18-445-104 Study Group are listed in the Supplementary Appendix, available at NEJM.org.Elizabeth Claire Elson, Joel Mermis, Deepika Polineni, Christopher M Oermann Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator ...Deepika Polineni 1 , Stephanie D Davis 2 , Sharon D Dell 3 Affiliations 1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, Kansas.Deepika Polineni; Background Elexacaftor-tezacaftor-ivacaftor is a small-molecule cystic fibrosis transmembrane conductance regulator (CFTR) modulator regimen shown to be efficacious in ...University of Kansas - Cited by 2,466 - cystic fibrosis - lung inflammation - extracellular vesicles - primary ciliary dyskinesiaBackground: This document presents the American Thoracic Society clinical practice guidelines for the diagnosis of primary ciliary dyskinesia (PCD). Target audience: Clinicians investigating adult and pediatric patients for possible PCD. Methods: Systematic reviews and, when appropriate, meta-analyses were conducted to summarize all available evidence pertinent to our clinical questions.Dr. Richard Braun, is an Internal Medicine specialist practicing in LEAWOOD, KS with 44 years of experience. . New patients are welcome.Background: Elexacaftor-tezacaftor-ivacaftor is a small-molecule cystic fibrosis transmembrane conductance regulator (CFTR) modulator regimen shown to be efficacious in patients with at least one Phe508del allele, which indicates that this combination can modulate a single Phe508del allele. In patients whose other CFTR …Author links open overlay panel Gregory S. Sawicki a, Andrea Goodman b, Callie Bacon a, Lauren Collins c, Jonathan Greenberg a, Christina Duncan d, Carla Frederick e, Shelby Luebbert f, Sylvia Mazuera f, Deepika Polineni g, Lori L. Stark h, …The American Thoracic Society's Public Advisory Roundtable (PAR) is pleased to invite you to our . 17th annual FREE patient/family education dayand Deepika Polineni, M.D., M.P.H. et al., for the VX18-445-104 Study Group * The members of the VX18-445-104 Study Group are listed in the Supplementary Appendix, available at NEJM.org.From Aug 25, 2020, to May 25, 2022, a total of 672 unique participants were screened for eligibility for one or both trials, resulting in 847 total random assignments across both trials with 594 unique participants. 370 participants were randomly assigned in the hypertonic saline trial and 477 in the dornase alfa trial.Europe PMC is an archive of life sciences journal literature.Background: This document presents the American Thoracic Society clinical practice guidelines for the diagnosis of primary ciliary dyskinesia (PCD). Target Audience: Clinicians investigating adult and pediatric patients for possible PCD. Methods: Systematic reviews and, when appropriate, meta-analyses were conducted to summarize all available evidence pertinent to our clinical questions.Matthias Griese 1 2 , Stefano Costa 3 , Rachel W Linnemann 4 , Marcus A Mall 5 6 , Edward F McKone 7 , Deepika Polineni 8 , Bradley S Quon 9 10 , Felix C Ringshausen 11 12 , Jennifer L Taylor-Cousar 13 , Nicholas J Withers 14 , Samuel M Moskowitz 15 , Cori L Daines 162020-21 Annual Report. Dear Pembroke Hill Community, On behalf of the students, faculty and staff of Pembroke Hill School, we thank you for your unwavering support and commitment to our school. Over the last year, you championed our faculty and staff, supported our students and provided resources which allowed us to remain focused on our work ...Deepika Polineni. Seattle Children's Hospital, University of Washington School of Medicine, Department of Pediatrics, Seattle, WA, USA. Dave Nichols. Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth-Hitchcock Medical Center, Department of Pulmonary and Critical Care Medicine, Lebanon, NH, USA.Garlow GM, Gettle LS, Felicetti NJ, Polineni D, Gifford AH. Perspectives on anemia and iron deficiency from the cystic fibrosis care community . Pediatric Pulmonology . 2019 Jul;54(7):939-940. doi: 10.1002/ppul.24323This webpage represents 1043332265 NPI record. The 1043332265 NPI number is assigned to the healthcare provider DEEPIKA POLINENI M.D., practice location address at 64 E 54TH ST KANSAS CITY, MO, 64112-2860. NPI record contains FOIA-disclosable NPPES health care provider information.Physician-scientists Gregory Gan and Deepika Polineni, who research cancer and cystic fibrosis, have teamed up to test a new drug with the potential to keep COVID-19 patients from needing a ventilator.We honor our many donors' generosity through this 2021-22 Annual Report. This publication includes the names of all of our donors who made pledges or gifts to the school, between July 1, 2021 and June 30, 2022, including to the Annual Fund, the Building Together Campaign, Memorials, Endowment Funds or Planned Giving.RESEARCH ARTICLE Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation Hong Dang ID 1*, Deepika Polineni2, Rhonda G. Pace1, Jaclyn R. Stonebraker1, Harriet Corvol3,4, Garry R. Cutting5,6, Mitchell L. Drumm7, Lisa J. Strug8,9, Wanda K. O'Neal1, Michael R. Knowles1 1 Marsico Lung Institute, University of North Carolina at Chapel Hill School of Medicine Cystic ...Dr. Deepika Polineni is an Internal Medicine doctor (Primary Care Physician) in Kansas City, KS, USA. Dr. Deepika Polineni is affiliated with University Of Kansas Hospital, Kansas University Physicians Inc. Dr. Deepika Polineni provides medical care in outpatient clinic and hospital setting.Thu, 05/28/2020. LAWRENCE — Chancellor Douglas A. Girod has approved promotion and the award of tenure where indicated to 97 individuals on the University of Kansas Medical Center and 62 individuals on the Lawrence and Edwards campuses. Girod and Barbara Bichelmeyer, the provost and executive vice chancellor, who chairs the University ...Deepika Polineni, MD, MPH. Associate Professor of Pediatrics, Allergy and Pulmonary Medicine. Director, Cystic Fibrosis Center. Click to see this content. Find great pulmonologists in Kansas City, KS. View profiles with insurance information, hours and location, other patients reviews, and more.We would like to show you a description here but the site won't allow us.Dr. Michael J. Holtzman is a Pulmonologist in Saint Louis, MO. Find Dr. Holtzman's phone number, address, insurance information, hospital affiliations and more.Introduction. Cystic fibrosis (CF) is the most common lethal genetic disorder in Caucasians, affecting an estimated 30,000 persons in the United States [].Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause abnormal ion transport at the apical membrane of airway epithelial cells, resulting in hyperviscous airway mucus [2, 3], and similar pathophysiology may ...Nasal lavage exosome analysis specifies therapeutic targets for precision treatment in cystic fibrosis Polineni, Deepika University of Kansas, Kansas City, KS, United StatesMichal Shteinberg, Iram J Haq, Deepika Polineni, Jane C Davies Published online: June 05, 2021 Cystic fibrosis is a life-limiting autosomal recessive disorder caused by mutations of the cystic fibrosis membrane conductance regulator (CFTR) gene.Dr. Deepika Polineni is an assistant professor of internal medicine in the Division of Pulmonary and Critical Care Medicine at the University of Kansas Health System, and …Amik Sodhi, Katherine Cox-Flaherty, Meredith Kendall Greer, Tasnim I Lat, Yuqing Gao, Deepika Polineni, Margaret A Pisani, Ghada Bourjeily, Marilyn K Glassberg, Caroly...> ;Chest. 2023 Feb 1 Longitudinal trends using a point-of-care gelatin-based model for ultrasound-guided central venous catheter insertion.Sex and Gender in Lung Diseases and Sleep Disorders: A State-of-the-Art Review: Part 2. Amik Sodhi, Katherine Cox-Flaherty, Meredith Kendall Greer, Tasnim I Lat, Yuqing Gao, Deepika Polineni ...Liked by Deepika Polineni. At the age of 23 she founded Tinder but after 2 years she was forced to leave the company because she was a victim of sexual harassment. At 25 she….When 2020 began, Gregory Gan, M.D., Ph.D., was all set to dive into new research on treatment resistance and metastasis in head and neck cancer. A few months and a global pandemic later, he's partnered with pulmonologist Deepika Polineni, M.D., MPH, and they have launched a trial together exploring a drug to fight COVID-19.Dr. Raksha Jain is a board certified pulmonary and critical care physician in Dallas, TX and is affiliated with multiple hospitals in the area, including University of Texas Southwestern Medical Center and Children's Medical Center Dallas. She received her medical degree from University of Texas Houston Health Science Center, completed Internal ...Dr. Derek E. Byers is a Pulmonologist in Saint Louis, MO. Find Dr. Byers's phone number, address, insurance information, hospital affiliations and more.Deepika Polineni. Associate Professor of Pediatrics. Division of Allergy & Pulmonary Medicine. https://orcid.org/0000-0001-8551-3734. 2422. Citations. 2006 2023. Research activity per year. Overview.Functional Role of Inflammasome Activation in a Subset of Obese Nonsmoking Patients with Severe Asthma"With treatments like this, we can actually anticipate that if a young child were started on this therapy, they could actually expect to have a normal life expectancy," said Deepika Polineni ...Matthias Griese 1 2 , Stefano Costa 3 , Rachel W Linnemann 4 , Marcus A Mall 5 6 , Edward F McKone 7 , Deepika Polineni 8 , Bradley S Quon 9 10 , Felix C Ringshausen 11 12 , Jennifer L Taylor-Cousar 13 , Nicholas J Withers 14 , Samuel M Moskowitz 15 , Cori L Daines 16Dr. Deepika Polineni, MD is a pulmonologist in Saint Louis, MO and has over 18 years of experience in the medical field. She graduated from UNIVERSITY OF MISSOURI / KANSAS CITY CAMPUS in 2004. She is affiliated with University Of Kansas Hospital. Her office accepts new patients. Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis. Andrea Hahn. , Aszia Burrell ...The 31st annual North American Cystic Fibrosis Conference (NACFC) was held in Indianapolis, IN on November 2–4, 2017. Abstracts of presentations from the conference were published in a supplement to Pediatric Pulmonology [2017; Pediatr Pulmonol Suppl. 52: S1‐S776]. 1 The current review summarizes several major topic areas addressed at the conference: the …Europe PMC is an archive of life sciences journal literature.Dr. Deepika Polineni in Kansas City, MO Address: 64 East 54Th, Deepika Polineni, Hong Dang, Paul J. Gallins, Lisa , Michal Shteinberg, Iram J Haq, Deepika Polineni, Jane C Davies. Cystic fibrosis, Singhasari (Javanese: ꦏꦫꦠꦺꦴꦤ꧀ꦱꦶꦔ꧀ꦲꦱꦫꦶ, romanized: Karaton Singhasari or Karaton Si, Deepika Polineni is a Pediatric Allergy and Immunologist and, Liked by Deepika Polineni. At the age of 23 she founded Tinde, Cystic fibrosis is a monogenic disease considered to affect at least 100 000 people worldwide. Mutations in CFTR,, The White Plague. Mohamad Badr Jandali, MD & Deepika Polineni,, Deepika Polineni, MD, MPH (she/her/hers) Washington University Sc, 22 Tem 2020 ... Deepika Polineni, MD, PhD, The Univer, Physician-scientists Gregory Gan and Deepika Polineni, who res, Dr. Jonathan B. Zuckerman is a Pulmonologist in South Port, HEALTH OUTCOMES ASSEMBLY: RACIAL AND ETHNIC DISPARITIES . Friday, Au, In publication since 1997, The Merrill Series on the R, Sylvia Mazuera f, Deepika Polineni g, Lori L. Stark h, Cynthia Geor, Alex H Gifford # 1 , Deepika Polineni # 2 , Jianghu, Deepika Polineni is a health care provider registered with Nation, KU Medical Center was one of the sites of a phase 3 t.